Publications for All Faculty
Genome editing technologies: defining a path to clinic.
An Integrative View of Microbiome-Host Interactions in Inflammatory Bowel Diseases.
Hypoxia drives transient site-specific copy gain and drug-resistant gene expression.
Jasmonate signalling in Arabidopsis involves SGT1b-HSP70-HSP90 chaperone complexes.
Do standard burn mortality formulae work on a population of severely burned children and adults?
Uncovering the Thermodynamics of Monomer Binding for RNA Replication.
Repurposing Salicylanilide Anthelmintic Drugs to Combat Drug Resistant Staphylococcus aureus.
Direct detection and drug-resistance profiling of bacteremias using inertial microfluidics.
Future Translational Applications From the Contemporary Genomics Era: A Scientific Statement From the American Heart Association.
Plant immunity triggered by engineered in vivo release of oligogalacturonides, damage-associated molecular patterns.
Discovery of a Small-Molecule Probe for V-ATPase Function.
Associations between host gene expression, the mucosal microbiome, and clinical outcome in the pelvic pouch of patients with inflammatory bowel disease.
Targeted disruption of DNMT1, DNMT3A and DNMT3B in human embryonic stem cells.
Targeted Plant Genome Editing via the CRISPR/Cas9 Technology.
Genomics of injury: The Glue Grant experience.
Simultaneous generation of many RNA-seq libraries in a single reaction.
Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature.
Pathogen-secreted proteases activate a novel plant immune pathway.
A novel role for KLF14 in T regulatory cell differentiation.
Chromatin regulation at the frontier of synthetic biology.
Replacing Uridine with 2-Thio-Uridine Enhances the Rate and Fidelity of Nonenzymatic RNA Primer Extension.
The Dynamics of the Human Infant Gut Microbiome in Development and in Progression toward Type 1 Diabetes.
Intake of farmed Atlantic salmon fed soybean oil increases hepatic levels of arachidonic acid-derived oxylipins and ceramides in mice.
A new antibiotic with potent activity targets MscL.
Exome Sequencing in Suspected Monogenic Dyslipidemias.
